FDA Inspection 1220643 — Parexel International (Ireland) Limited
The FDA completed an inspection of Parexel International (Ireland) Limited on September 22, 2023 in Dublin 8. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 22, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Dublin 8 (Ireland)
Additional Details
Sponsor, Contract Research Organization